What is ArriVent BioPharma, Inc.'s change in AP?

ArriVent BioPharma, Inc. (AVBP) reported change in AP of $2.81M in Q1 2026.

How has ArriVent BioPharma, Inc.'s change in AP changed year-over-year?

ArriVent BioPharma, Inc.'s change in AP increased by 382.3% year-over-year, from $582K to $2.81M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

ArriVent BioPharma, Inc. AVBP Change in AP

Change in AP at other companies

Johnson & JohnsonJNJ

-$3.92B-84.4%

Syndax PharmaceuticalsSNDX

-$5.74M-263%

Nuvation BioNUVB

$12.96M+209%

ImmunomeIMNM

$1.42M+137%

Arcus BiosciencesRCUS

-$3M-200%

Erasca, Inc.ERAS

$1.18M-34.1%

Other financials

Income statement

See full

Operating income-$46.1M+30.9%

Net income-$43.3M+32.7%

EPS (diluted)-$0.96+49.5%

Balance sheet

See full

Cash & equivalents$62.1M+24.5%

Total debt$419.0K+204%

Total equity$324.0M+60.0%

Total assets$349.3M+62.1%

Cash flow

See full

Operating cash flow-$41.9M+38.4%

Valuation

See full

Market cap$1.57B+62.1%

Enterprise value$1.51B+65.4%

Returns & leverage

See full

Return on equity-55.2%+8.0pp

Debt / equity0×0.0×

Current ratio14×-0.4×

Where this comes from

Reported directly by ArriVent BioPharma, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableTrade.

The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about ArriVent BioPharma, Inc.'s change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ArriVent BioPharma, Inc.'s change in AP?: ArriVent BioPharma, Inc. (AVBP) reported change in AP of $2.81M in Q1 2026.
How has ArriVent BioPharma, Inc.'s change in AP changed year-over-year?: ArriVent BioPharma, Inc.'s change in AP increased by 382.3% year-over-year, from $582K to $2.81M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.